XSTO
ESSITY A
Market cap18bUSD
Sep 17, Last price
264.00SEK
1D
0.00%
1Q
-1.31%
IPO
9.09%
Name
Essity AB (publ)
Chart & performance
P/E
14.13
P/S
1.29
EPS
18.68
Div yield, %
3.13%
Shrs. gr., 5y
-0.38%
Rev. gr., 5y
2.61%
Revenues
138.49b
-4.85%
Net income
12.66b
-39.41%
CFO
15.46b
-7.99%
Dividend
Mar 27, 20268.75 SEK/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Essity AB engages in the development, production, and marketing of personal care products. It operates through the following segments: Personal Care, Consumer Tissue, Professional Hygiene, and Other Operations. The Personal Care segment offers incontinence products, baby care, feminine care, and medical solutions. The Consumer Tissue segment consists of toilet paper, household towels, handkerchiefs, facial tissues, wet wipes, and napkins. The Professional Hygiene segment comprises complete hygiene solutions, including toilet paper, paper hand towels, napkins, hand soap, hand lotion, hand sanitizers, dispensers, cleaning and wiping products, internet of things sensor technology, and service and maintenance. The Other Operations segment refers to the group-wide functions. The company was founded in 1929 and is headquartered in Stockholm, Sweden.
Related entities
Subsidiaries (83)
PRODUCTOS FAMILIA CAJICA S A S
Productos Familia Rionegro S.A.S.
PRODUCTOS FAMILIA S.A.
Key people
President, Chief Executive Officer, Director · since 2017
Robert Sjostrom
President, Global Operational Services · since 2018
Tuomas Yrjola
President, Global Brand, Innovation and Sustainability · since 2018
Senior Vice President, Group Function Legal Affairs, General Counsel, Secretary to the Board
Legal address
Box 200
STOCKHOLM, AB 101 23
SE
STOCKHOLM, AB 101 23
SE
Headquarters
Klarabergsviadukten 63
Stockholm, AB 111 64
SE
Stockholm, AB 111 64
SE
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||